Literature DB >> 19940304

Denosumab, osteoporosis, and prevention of fractures.

Stefan Kiechl, Johann Willeit, Georg Schett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19940304     DOI： 10.1056/NEJMc091893

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Tromsø study.

Authors:  Anders Vik; Ellen E Brodin; Ellisiv B Mathiesen; Jan Brox; Lone Jørgensen; Inger Njølstad; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  Eur J Epidemiol       Date:  2014-12-02       Impact factor: 8.082

Review 2.  Mechanisms of action of therapeutic antibodies for cancer.

Authors:  J M Redman; E M Hill; D AlDeghaither; L M Weiner
Journal:  Mol Immunol       Date:  2015-04-23       Impact factor: 4.407
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.